GlassScriptPhysician profile
Scott Watkins
NPI 1346903069
$2,029.63
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,661 · 2023: $369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $369.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $368.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $308.71 | 2022 | |
| Janssen Pharmaceuticals, INC | $290.48 | 2022-2023 | Xarelto |
| Actelion Pharmaceuticals US, INC. | $266.46 | 2022-2023 | Uptravi |
| Edwards Lifesciences Corporation | $182.42 | 2022-2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Merck Sharp & Dohme LLC | $155.95 | 2022-2023 | Verquvo |
| Novartis Pharmaceuticals Corporation | $148.41 | 2022-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $137.09 | 2022-2023 | Jardiance |
| Sanofi-Aventis U.S. LLC | $98.31 | 2022-2023 | |
| Amgen INC. | $92.57 | 2022-2023 | Repatha |
| Astrazeneca Pharmaceuticals LP | $61.89 | 2022-2023 | Brilinta |
| Boston Scientific Corporation | $61.39 | 2022-2023 | Rotapro |
| Alnylam Pharmaceuticals INC. | $59.24 | 2022-2023 | Amvuttra |
| Atricure, INC. | $45.31 | 2022 | |
| Esperion Therapeutics, INC. | $31.74 | 2022 | |
| Biotronik INC. | $25.82 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $20.12 | 2022 | |
| Eisai INC. | $15.33 | 2023 | |
| Medtronic, INC. | $15.30 | 2022 | |
| Impulse Dynamics (USA) INC. | $13.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Watkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.